Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients

Tissue Antigens

Volumn 80, Issue 4, 2012, Pages 322-327

  Cosentini, E ^a   Gargiulo, L ^b,d   Bruno, P ^a   Lastraioli, S ^b   Risitano, A ^a   Camerlingo, R ^c   Luongo, V ^a   Serra, M ^b   Sica, M ^d   Garzillo, C ^a   Giani, U ^a   Notaro, R ^b,d   Alfinito, F ^a   Ruggiero, G ^a   Terrazzano, G ^a,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d ISTITUTO TOSCANO TUMORI   (Italy)

^e UNIVERSITY OF BASILICATA   (Italy)

Author keywords

Immune mediated disease; Killer immunoglobulin like receptors; Killer immunoglobulin like receptors human leukocyte antigen ligand; Paroxysmal nocturnal haemoglobinuria

Indexed keywords

HLA ANTIGEN; HLA B14 ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE FREQUENCY; GENE INACTIVATION; GENE REPRESSION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HAPLOTYPES; HEMOGLOBINURIA, PAROXYSMAL; HLA-B ANTIGENS; HUMANS; ITALY; KILLER CELLS, NATURAL; LIGANDS; MALE; MIDDLE AGED; MOLECULAR TYPING; RECEPTORS, KIR3DL1; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84866598352     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01932.x     Document Type: Article

References (32)

1. Luzzatto L. Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism. Curr Opin Genet Dev 2006: 16: 317-22.
2. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal population of hematopoietic cell with paroxysmal nocturnal hemoglobinuria phenotype are present in normal individuals. Proc Natl Acad Sci USA 1999: 96: 5209-14.
3. Rosti V, Tremml G, Soares V, Pandolfi PP, Luzzatto L, Bessler M. Murine embrionic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest 1997: 100: 1028-36.
4. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell 1997: 88: 1-4.
5. Karadimitris A, Manavalan JS, Thaler HT et al. Abnormal T cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 2000: 96: 2613-20.
6. Gargiulo L, Lastraioli S, Cerruti G et al. Highly homologous T-cell receptor beta sequence support a common target for auto-reactive T cells in most patients with paroxysmal nocturnal hemoglobinuria. Blood 2007: 109: 5036-42.
7. Terrazzano G, Sica M, Becchimanzi C et al. T cells from Paroxysmal Nocturnal Hemoglobinuria PNH) patients show an altered CD40-dependent pathway. J Leukoc Biol 2005: 78: 27-36.
8. Poggi A, Negrini S, Zocchi MR et al. Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors. Blood 2005: 106: 2399-408.
9. van Bijnen STA, Withaa M, Preijers F et al. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2Cand NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines. Exp Hematol 2011: 39: 751-62.
10. Maciejewski JP, Follmann D, Nakamura R et al. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood 2001: 98: 3513-9.
11. Lombardi ML, Terrazzano G, Cosentini E et al. Paroxysmal nocturnal hemoglobinuria: significant association with specific HLA-A, B, C and DR alleles in Italian patients. Hum Immunol 2008: 69: 202-6.
12. Hanaoka N, Kawaguchi T, Horikawa K, Nagakura S, Mitsuya H, Nakakuma H. Immunoselection by natural killer cells of PIG-A mutant cells missing stress-inducible ULBP. Blood 2006: 107: 1184-91.
13. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008: 9: 503-10.
14. Lanier LL. NK cell recognition. Annu Rev Immunol 2005: 23: 225-74.
15. Caligiuri MA. Human natural killer cells. Blood 2008: 112: 461-9.
16. Parham P. MHC Class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005: 5: 201-14.
17. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004: 4: 190-8.
18. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cell. Cell 2010: 140: 619-30.
19. Gleimer M, Parham P. Stress management: MHC Class I and Class I like molecules as reporters of cellular stress. Immunity 2003: 19: 469-77.
20. Moretta L, Ferlazzo G, Bottino C et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006: 214: 219-28.
21. Flodstrom-Tullberg M, Bryceson YT, Shi F-D, Höglund P, Ljunggren H-G. Natural killer cells in human autoimmunity. Curr Opin Immnunol 2009: 21: 634-40.
22. Rajagopalan S, Long EO. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 2005: 201: 1025-9.
23. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 2008: 118: 1017-26.
24. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006: 203: 633-45.
25. Howe EC, Wlodarski M, Ball EJ, Rybicki L, Maciejewski JP. Killer Immunoglobulin-like Receptor genotype in immune-mediated bone marrow failure syndromes. Exp Hematol 2005: 33: 1357-62.
26. Parker C, Omine M, Richards S et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005: 106: 3699-709.
27. de Latour RP, Mary JY, Salanoubat C et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 2008: 112: 3099-106.
28. Sun YJ, Gaidulis L, Miller MM et al. Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 2004: 64: 462-8.
29. van der Slik AR, Koeleman BPC, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003: 52: 2639-42.
30. Rendine S, Borelli I, Barbanti M, Sacchi N, Roggero S, Curtoni ES. HLA polymorphisms in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998: 52: 135-46.
31. Bontadini A, Testi M, Cuccia MC et al. Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. J Transl Med 2006: 4: 44-52.
32. Zeng W, Miyazato A, Chen G, Kajigaya S, Young N, Maciejewskj JP. Interferon-γ-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood 2006: 107: 167-75.